Log in
Enquire now
ATB Therapeutics

ATB Therapeutics

Antibody therapies developer for oncology and auto-immune disease.

OverviewStructured DataIssuesContributors

Contents

atbtherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Therapeutics
Therapeutics
Pharmaceutical industry
Pharmaceutical industry
Location
Belgium
Belgium
CEO
‌
Bertrand Magy
Founder
‌
Bertrand Magy
‌
Max Houry
Number of Employees (Ranges)
11 – 50
Email Address
info@atbtherapeutics.com
Investors
EQT Life Sciences
EQT Life Sciences
V-Bio Ventures
V-Bio Ventures
MRL Ventures
MRL Ventures
Sambrinvest
Sambrinvest
‌
SFPIM
Founded Date
2018
Total Funding Amount (USD)
56,600,000
Latest Funding Round Date
November 18, 2024
Latest Funding Type
Series A
Series A
COO
‌
Max Houry

Other attributes

Latest Funding Round Amount (USD)
56,600,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like ATB Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.